Issue of Equity to Vendors of Lucas Fettes

Brooks Macdonald Group PLC
11 December 2024
 

11 December 2024

 

BROOKS MACDONALD GROUP PLC

(the "Company")

 

Issue of Equity to Vendors of Lucas Fettes

Further to the Company's announcement regarding the acquisition of Lucas Fettes Holdings Limited ("Lucas Fettes"), Brooks Macdonald, a leading wealth management firm, announces it has issued 12,571 ordinary shares in the Company ("Consideration Shares"). These shares form part of the consideration for the acquisition and have been issued to the vendors of Lucas Fettes.

Admission and Total Voting Rights

 

Application has been made for the admission of the Consideration Shares to be admitted to trading on AIM ("Admission"). The Consideration Shares will rank pari passu with the existing issued ordinary shares of the Company. It is expected that Admission will become effective and that trading in the new ordinary shares will commence at or around 8.00 am on 17 December 2024.

 

On Admission, the total number of ordinary shares in the Company will be 16,520,539. The Company does not currently hold any ordinary shares in treasury. Therefore, from Admission, the total number of voting rights in the Company will be 16,520,539, and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Enquiries:

 

Brooks Macdonald Group plc

  +44 (0)20 7927 4816

Andrea Montague, CEO

Katherine Jones, CFO

 

 




Singer Capital Markets (Nominated Adviser and Joint Broker)

Charles Leigh-Pemberton / James Moat

 

+44 (0)20 7496 3000

Investec Bank plc (Joint Broker)

Chris Baird / David Anderson

 

+44 (0)20 7597 4000

 

 

LEI: 213800WRDF8LB8MIEX37

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100